IGEA Pharma NV
F:3B5

Watchlist Manager
IGEA Pharma NV Logo
IGEA Pharma NV
F:3B5
Watchlist
Price: 16.791 EUR -3.07% Market Closed
Market Cap: €10.6m

Multiples-Based Value

3B5 price has not been updated for more than 5 years. This may indicate that the stock has been delisted.
3B5 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the multiples-based value of 3B5.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

3B5 Multiples-Based Value
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

3B5 Competitors Multiples
IGEA Pharma NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
NL
IGEA Pharma NV
F:3B5
505.5k EUR 0 0.4 -3 -3
US
Abbott Laboratories
NYSE:ABT
174.2B USD 3.9 26.8 15.3 21.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
160B USD 16.1 56.8 43 52.8
US
Stryker Corp
NYSE:SYK
129.7B USD 5.3 40.7 20.7 25.1
IE
Medtronic PLC
NYSE:MDT
111.9B USD 3.2 24.4 13.4 19.6
US
Boston Scientific Corp
NYSE:BSX
91.6B USD 4.7 32.3 19.1 25.7
DE
Siemens Healthineers AG
XETRA:SHL
42.6B EUR 1.8 20.2 11.3 15.9
US
Edwards Lifesciences Corp
NYSE:EW
45.2B USD 7.5 42.2 23.1 25.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.9B USD 10.6 43.2 30.6 33.9
US
Becton Dickinson and Co
NYSE:BDX
43.9B USD 2 25.2 10 16.8
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
33.4B USD 1.6 16.1 11.6 14
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett